Gritsiuk A I, Ivanova N V
Kardiologiia. 1981 Aug;21(8):22-8.
It is shown that the erythrocytes of patients suffering from chronic ischaemic heart disease have normal or increased procoagulant, decreased anticoagulant and fibrinolytic activity, i.e. they enhance the increased coagulating and decrease the fibrinolytic potential of plasma in this group of patients. Addition of syncumar to the combined treatment causes certain decrease of the erythrocyte hypercoagulation potential, though it still remains marked. The fibrinolytic activity of plasma and erythrocytes remains unchanged.
结果表明，患有慢性缺血性心脏病的患者的红细胞具有正常或增加的促凝活性、降低的抗凝和纤溶活性，即它们增强了该组患者血浆中升高的凝血作用并降低了纤溶潜能。在联合治疗中添加新抗凝会使红细胞的高凝潜能有所降低，尽管其仍很显著。血浆和红细胞的纤溶活性保持不变。
